Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease.
Nakamura
Satoshi
S
Yoshinocho Eye Clinic, 4-26-3 Sannoucho, Minami-ku, Yokohama 232-0013, Japan.
Ohno
Shigeaki
S
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014792:Visual Acuity
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab